| Year |
Citation |
Score |
| 2022 |
Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, Korman LY, Ford CB, Litcofsky KD, Lombardo MJ, Wortman JR, ... ... Trucksis M, et al. SER-109, an Oral Microbiome Therapy for Recurrent Infection. The New England Journal of Medicine. 386: 220-229. PMID 35045228 DOI: 10.1056/NEJMoa2106516 |
0.587 |
|
| 2020 |
McGovern BH, Ford CB, Henn MR, Pardi DS, Khanna S, Hohmann EL, O'Brien EJ, Desjardins CA, Bernardo P, Wortman JR, Lombardo MJ, Litcofsky KD, Winkler JA, McChalicher CWJ, Li SS, ... ... Trucksis M, et al. SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32255488 DOI: 10.1093/Cid/Ciaa387 |
0.587 |
|
| 2007 |
Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, Samala R, Joshi S, Hemming VG, Trucksis M. The American cotton rat: a novel model for pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland). 87: 145-54. PMID 16973421 DOI: 10.1016/j.tube.2006.07.001 |
0.35 |
|
| 2006 |
Pagán-Ramos E, Master SS, Pritchett CL, Reimschuessel R, Trucksis M, Timmins GS, Deretic V. Molecular and physiological effects of mycobacterial oxyR inactivation. Journal of Bacteriology. 188: 2674-80. PMID 16547055 DOI: 10.1128/Jb.188.7.2674-2680.2006 |
0.61 |
|
| 2004 |
Ruley KM, Ansede JH, Pritchett CL, Talaat AM, Reimschuessel R, Trucksis M. Identification of Mycobacterium marinum virulence genes using signature-tagged mutagenesis and the goldfish model of mycobacterial pathogenesis. Fems Microbiology Letters. 232: 75-81. PMID 15019737 DOI: 10.1016/S0378-1097(04)00017-5 |
0.596 |
|
| 2002 |
Ruley KM, Reimschuessel R, Trucksis M. Goldfish as an animal model system for mycobacterial infection. Methods in Enzymology. 358: 29-39. PMID 12474377 DOI: 10.1016/s0076-6879(02)58079-4 |
0.312 |
|
| Show low-probability matches. |